| Charles Fink Peebles, DPM | |
|
5600 Roswell Rd Ne, Suite M-190, Atlanta, GA 30342-1150 | |
| (404) 255-9131 | |
| Not Available |
| Full Name | Charles Fink Peebles |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 29 Years |
| Location | 5600 Roswell Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184684862 | NPI | - | NPPES |
| 160059112A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0000X | Podiatrist - Sports Medicine | POD000796 (Georgia) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD000796 (Georgia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Breckinridge Memorial Hospital | Hardinsburg, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Breckinridge Health, Inc. | 0941106454 | 15 |
| Scott J. Giaimo, Dpm, Pllc | 5698946580 | 5 |
News Archive
Small employers are traditionally faced with a difficult choice when providing health coverage for their employees: they can either choose benefits that are affordable, or spend more and offer their employees a choice.
CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
The California HealthCare Foundation (CHCF) has launched a $10-million investment fund targeting nonprofit organizations and for-profit companies with innovative services, devices, and technologies that can significantly reduce costs and improve access to care in California.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 2 days ago
| Provider Name | Breckinridge Health, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1104828383 PECOS PAC ID: 0941106454 Enrollment ID: O20031208000333 |
News Archive
Small employers are traditionally faced with a difficult choice when providing health coverage for their employees: they can either choose benefits that are affordable, or spend more and offer their employees a choice.
CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
The California HealthCare Foundation (CHCF) has launched a $10-million investment fund targeting nonprofit organizations and for-profit companies with innovative services, devices, and technologies that can significantly reduce costs and improve access to care in California.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 2 days ago
| Provider Name | Scott J. Giaimo, Dpm, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134407331 PECOS PAC ID: 5698946580 Enrollment ID: O20110926000738 |
News Archive
Small employers are traditionally faced with a difficult choice when providing health coverage for their employees: they can either choose benefits that are affordable, or spend more and offer their employees a choice.
CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
The California HealthCare Foundation (CHCF) has launched a $10-million investment fund targeting nonprofit organizations and for-profit companies with innovative services, devices, and technologies that can significantly reduce costs and improve access to care in California.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 2 days ago
| Provider Name | 360care Services Of Kentucky Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669113023 PECOS PAC ID: 9931587888 Enrollment ID: O20220604000305 |
News Archive
Small employers are traditionally faced with a difficult choice when providing health coverage for their employees: they can either choose benefits that are affordable, or spend more and offer their employees a choice.
CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
The California HealthCare Foundation (CHCF) has launched a $10-million investment fund targeting nonprofit organizations and for-profit companies with innovative services, devices, and technologies that can significantly reduce costs and improve access to care in California.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Fink Peebles, DPM 5600 Roswell Rd Ne, Suite M-190, Atlanta, GA 30342-1150 Ph: (404) 255-9131 | Charles Fink Peebles, DPM 5600 Roswell Rd Ne, Suite M-190, Atlanta, GA 30342-1150 Ph: (404) 255-9131 |
News Archive
Small employers are traditionally faced with a difficult choice when providing health coverage for their employees: they can either choose benefits that are affordable, or spend more and offer their employees a choice.
CN Bio today announced it has received a grant from Innovate UK to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
The California HealthCare Foundation (CHCF) has launched a $10-million investment fund targeting nonprofit organizations and for-profit companies with innovative services, devices, and technologies that can significantly reduce costs and improve access to care in California.
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting on February 24-27, 2010, in Marco Island, Florida.
A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that, on May 18, 2010, the Company received a letter from The Nasdaq Stock Market (Nasdaq) indicating that the minimum closing bid price of its common stock had fallen below $1.00 for 30 consecutive trading days, and therefore, A.P. Pharma was not in compliance with Marketplace Rule 5550(a)(2).
› Verified 2 days ago
Ayanda Dube, Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-727-5658 | |
Dr. Barbara S. Schlefman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2789 Joel Pl, Atlanta, GA 30360 Phone: 770-604-3803 | |
Primera Foot & Ankle Centers Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1150 Hammond Dr Bldg E, Suite 600, Atlanta, GA 30328 Phone: 678-395-3628 Fax: 678-691-5164 | |
Dr. Frank Andrew Sinkoe, OPM DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1935 Cliff Valley Way Ne, 118, Atlanta, GA 30329 Phone: 404-329-5050 Fax: 404-329-5005 | |
Diabetic Foot Care Specialist Of Georgia Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 238 Walker St Sw, Unit #12, Atlanta, GA 30313 Phone: 404-759-6755 Fax: 334-271-3768 | |
Margo Angela Jimenez, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2295 Parklake Dr Ne Ste 150, Atlanta, GA 30345 Phone: 770-938-5974 Fax: 770-939-4450 | |
Mystic Medical, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 5555 Glenridge Connector, Suite 200, Atlanta, GA 30342 Phone: 404-351-0055 |